![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 23, 2014 2:54:20 PM
$IDRA Per 10-K, "IMO-8400 ... results of inducing cell death in tumor cells harboring the MYD88 L265P oncogenic mutation." WaldenstromsDLBCL
$IDRA 90% of WM patients carry the MYD88 L265P oncogenic mutation
$IDRA Between the lines: Upped dosage, expanded cohorts, Julian Baker on BoD, insider buying, and new cancer platform. Data gon be gooooood!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM